ARCHIVES

NCI To Pay 34 Percent Of Grants, At 155 Payline; $100 Million for Centers to Fund All Core Grants

This article is from The Cancer Letter archive.

Vol. 14 No. 05 | January 29, 1988

Download PDF Visit The Full Archive

Related Articles

Three Genetics Pioneers Win Nobel Prize

October 11, 2002

Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds

January 29, 2010

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

HHS Carcinogen Guidelines Draft

June 13, 1980

Pesticides Not A Risk Factor For Long Island Breast Cancer, Study Finds

September 6, 2002

Pazdur Waxes On Calumet City And Krebiozen; Parkinson Takes Interim CMO Job at Zyngenia

April 27, 2012